Beijing Sunho Pharmaceutical Co (BJSE:430017) Cash-to-Debt : 76.47 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Sunho Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Beijing Sunho Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 76.47.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Beijing Sunho Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Beijing Sunho Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

BJSE:430017' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.93 Med: 75.47 Max: No Debt
Current: 76.47

During the past 13 years, Beijing Sunho Pharmaceutical Co's highest Cash to Debt Ratio was No Debt. The lowest was 1.93. And the median was 75.47.

BJSE:430017's Cash-to-Debt is ranked better than
87.06% of 989 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs BJSE:430017: 76.47

Beijing Sunho Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Beijing Sunho Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Beijing Sunho Pharmaceutical Co Cash-to-Debt Chart

Beijing Sunho Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

17.48

344.15

8.26

No Debt

Beijing Sunho Pharmaceutical Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	77.55	74.47	71.12	76.47

Competitive Comparison of Beijing Sunho Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sunho Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Sunho Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Sunho Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Beijing Sunho Pharmaceutical Co's Cash-to-Debt falls into.

Beijing Sunho Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Beijing Sunho Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Beijing Sunho Pharmaceutical Co had no debt ⁽¹⁾.

Beijing Sunho Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	765.24	/	(10.007	+	0)
	=	76.47

Beijing Sunho Pharmaceutical Co (BJSE:430017) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Beijing Sunho Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Beijing Sunho Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sunho Pharmaceutical Co Ltd (BJSE:430017) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.sunho.com.cn

Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and innovative drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Headlines

No Headlines